Table 2. Hematologic and molecular diagnostic data of patients with SCA.

Note:*RBC, red blood cell; Hb, hemoglobin concentration; MCV, mean cell volume; MCH, mean corpuscular hemoglobin

Pt.	Age	Sex	RBC (10^12cells/L)	HGB (g/L)	MCV (10^-14 L/cells	MCH (10^-11 g/cells)	B12 (pmol/L)	Folic Acid (nmol/L)	Hb S (%)	Hb A2 (%)	Hb A0 (%)	Hb F (%)	Genotype (Only pathogenic variants shown)	Phenotype
1	19	M	2.82	86	8.76	3.05	231	> 45	61.7	4.5	10.7	28	-	Hb S/β
2	38	F	3.69	84	7.05	2.28	312	24	46.4	5.8	46.2	1.6	heterozygous c.20A>T, heterozygous c.25_26delAA	Hb S/β0
3	40	F	3.46	91	7.80	2.63	188	> 45	44.9	5.4	44.2	5.5	heterozygous c.20A>T	Hb S Carrier
4	35	F	2.84	65	7.15	2.29	154	17	50.8	5.5	40.7	3.0	heterozygous c.20A>T, heterozygous c.316-106C>G	Hb S/β+
5	35	F	2.06	76	10.19	3.69	364	15	69.9	4.9	20.3	4.9	homozygous c.20A>T	Hb SS
6	54	M	5.48	120	6.55	2.19	-	-	-	5.3	14.9	1.8	heterozygous c.93-21 G>A, heterozygous c.364G>A	Hb O-Arab/β+
7	38	F	3.37	74	6.71	2.20	-	-	72.5	6.1	13.2	8.2	herterozygousc.20A>T, heterozygous c.93-21G>A	Hb S/β+
8	24	F	2.55	59	7.37	2.31	-	17	76.7	6.9	9.0	7.4	heterozygous c.20A>T, heterozygous c.316-106C>G	Hb S/β+
9	42	M	2.84	86	8.59	3.03	441	39	82.2	4.9	2.9	10	homozygous c.20A>T	Hb SS
10	60	F	2.19	85	11.05	3.88	242	18	48.3	5.2	4.0	42.5	heterozygous c.315+1G>A, heterozygous c.20A>T	Hb S/β0
11	54	F	2.72	53	5.90	1.95	352	-	82.8	6.1	3.4	7.7	-	Hb S/β
12	26	M	3.45	96	7.68	2.78	245	12	77	3.7	4.6	14.7	homozygous c.20A>T	Hb SS
13	30	F	2.61	100	9.89	3.83	-	-	78.5	4.7	3.0	13.8	homozygous c.20A>T	Hb SS
14	18	F	3.79	92	7.28	2.43	-	-	69.5	6.5	11.4	12.6	heterozygous c.20A>T, heterozygous c.93-21G>A	Hb S/β+